← Eichor
Study identifier: NCT05642572 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Condition: Recurrent Lung Non-Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8  ·  Sponsor: SWOG Cancer Research Network

PhasePhase 2
Planned participants66
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This phase II Lung-MAP treatment trial test the combination of targeted drugs (capmatinib, osimertinib, and/or ramucirumab) in treating patients with non-small cell lung cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and that has EGFR and MET gene changes. Capmatinib and osimertinib are in a class of medications called kinase inhibitors. They work by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells and may help shrink tumors. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Giving capmatinib, osimertinib, and/or ramucirumab and targeting abnormal gene changes in tumor cells may be effective in shrinking or stabilizing advanced non-small cell lung cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (454)

Gulf Health Hospitals Inc/Infirmary Cancer Care - MalbisDaphne, Alabama, United StatesRecruiting
Thomas HospitalFairhope, Alabama, United StatesRecruiting
Mobile Infirmary Medical CenterMobile, Alabama, United StatesRecruiting
Gulf Health Hospitals Inc/Infirmary Cancer Care - SaralandSaraland, Alabama, United StatesRecruiting
Katmai Oncology GroupAnchorage, Alaska, United StatesRecruiting
Kingman Regional Medical CenterKingman, Arizona, United StatesRecruiting
Cancer Center at Saint Joseph'sPhoenix, Arizona, United StatesSuspended
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - JonesboroJonesboro, Arkansas, United StatesRecruiting
University of Arkansas for Medical SciencesLittle Rock, Arkansas, United StatesRecruiting
Kaiser Permanente-AnaheimAnaheim, California, United StatesActive Not Recruiting
Mission Hope Medical Oncology - Arroyo GrandeArroyo Grande, California, United StatesSuspended
PCR OncologyArroyo Grande, California, United StatesRecruiting

+ 442 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05642572